Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies

20260 citationsJournal Articlegold Open Access

Authors

Clinicaltrials.gov, NCT03745638 and NCT03745651 (studies registered November 19, 2018).

Published in: Dermatology and Therapy

Volume 16, Issue 3, pp. 1635-1646

Field-Weighted Citation Impact: 0.00